This figure is approximately twice as high as that of major companies in the same industry. Celltrion's permanent employee count is 2,680, while Hanmi Pharmaceutical and Chong Kun Dang have 2,345 and 2,253 employees, respectively, highlighting Samsung Biologics' overwhelming scale. The secret to Samsung Biologics' explosive growth lies in a virtuous cycle of 'performance growth-employment expansion.' Last year's revenue was 4.5473 trillion KRW, an increase of more than 15 times compared to 294.6 billion KRW in 2016, the year of its listing. The compound annual growth rate (CAGR) over the same period exceeded 40%, significantly outperforming the average growth rate of the global CDMO (Contract Development and Manufacturing Organization) industry. Notably, with record-high performance in the first half of this year, the company raised its annual revenue growth guidance from the original 20-25% to 25-30%. This stable performance growth is continuously leading to sustained workforce expansion. Samsung Biologics' expansion of production capacity is also a key driver for recruiting specialized personnel. Starting with the operation of Plant 1, with a capacity of 30,000 liters in 2013, the company now operates a total of six plants, securing a world-leading production capacity of 784,000 liters. By completing new plants every 2-3 years on average and shortening ramp-up periods, the company is rapidly responding to the large-scale demands of global pharmaceutical companies. Even more noteworthy is the establishment of an organizational culture based on diversity and inclusion, beyond mere workforce expansion. The proportion of women among all employees is 45%, which is the highest level in Korea for a manufacturing-centric industry. The company operates an in-house daycare center equipped with state-of-the-art facilities to support work-life balance and provides parental leave for up to two years per child. The utilization rate of paternity leave for male employees is 90%, and these efforts have led to the company being recognized as a 'Family-Friendly Excellent Company' by the Ministry of Gender Equality and Family for 10 consecutive years. Samsung Biologics has established itself as the largest employer in the Songdo area of Incheon, positively impacting regional economic revitalization. Beyond simple job creation, the company is actively fostering highly skilled bio-specialized personnel, contributing to the qualitative expansion of employment across the local community and the national economy.